Trials / Completed
CompletedNCT00395408
Linear Growth Study (0476-097)(COMPLETED)
A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing the Effect on Linear Growth of Montelukast With Placebo and Inhaled Beclomethasone in Pediatric Patients (Prepubertal, Tanner Stage I) With Mild Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 360 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 6 Years – 8 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effect of montelukast with placebo and beclomethasone on the average rate of linear growth over a period of 56 weeks in children with mild asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium / Duration of Treatment : 56 Weeks | |
| DRUG | Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weeks |
Timeline
- Start date
- 2000-06-01
- Primary completion
- 2003-12-01
- Completion
- 2003-12-01
- First posted
- 2006-11-02
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00395408. Inclusion in this directory is not an endorsement.